|Event Name||Oxford Global 2013 8th Annual Biomarkers Congress
Tuesday, February 19, 2013
Wednesday, February 20, 2013
Hilton Manchester Deansgate Hotel
|Description||The pharmaceutical industry is facing high clinical development costs and declining drug discovery success rates. To stay competitive companies are re-evaluating their drug development process to reduce attrition rates. Biomarkers promise to transform drug discovery, clinical development and diagnostics in the R&D process as effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity.